Smartwatch-detected arrhythmias : characteristics, management and short-term outcomes - The CONNECT study -

14 April 2026 (08:00 - 14:45)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Mr Pierre-Alexandre Salame

University Hospital of Poitiers, Poitiers (France)

188 More presentations in this session

Presentation thumbnail

Comparison of ECG findings between young patients with cryptogenic ischemic stroke and stroke-free control subjects

Doctor J. Uutela (Jyvaskyla, FI)

Presentation thumbnail

A wearable SCG-based approach for early, low-cost screening of valvular heart disease

Doctor V. Pergola (Naples, IT)

Presentation thumbnail

Intraoperative assessment of cardiac parasympathetic tone using short-term HRV metrics before and after atropine administration: a pilot study

Doctor B. Hrymniak (Wroclaw, PL)

Presentation thumbnail

Arrhythmia phenotypes in hair-loss therapies: insights from minoxidil and finasteride reports in eudravigilance

Doctor Y. Shhab (Bucharest, RO)

Presentation thumbnail

Arrhythmias and device therapy in HFpEF: Insights from a real-world hospital cohort

Ms A. Bondoc (Timisoara, RO)

Abstract Slides Video

Access the full session

Session thumbnail

Poster session (3): mechanisms and management of arrhythmias

The Event

Event poster

EHRA 2026

14 April 2026 08:00 CET

You may be interested in

Congress Presentation

Enhanced Detection and Quickened Diagnosis of Atrial Fibrillation Using Apple Watch: A Randomized Controlled Trial

Congress Presentation

‘My smart watch showed atrial fibrillation’ (AF): who and how to evaluate

Congress Presentation

Is a single-lead smartwatch ECG capable of detecting a wider spectrum of arrhythmias in clinical practice?

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources